RAND Europe is evaluating the implementation and delivery of Individual Placement and Support (IPS), an evidence-based intervention to support people into employment.
RAND Europe reviewed pathogen surveillance initiatives to to identify the gaps and determine how this tool can be used to inform public health decisionmaking.
In several locations across England and Wales, NHS organisations responsible for managing acute hospitals have also taken over the running of primary care medical practices. Vertical integration is a valuable option to consider when GP practices look likely to fail due to recruitment and financial difficulties, but it is not an option that should be imposed from the top down.
The Ministry of Justice (MoJ) and His Majesty’s Prisons and Probation Service jointly commissioned RAND Europe to conduct a research study to examine and evaluate how drug testing regimens and incentivised substance free living wings are implemented in prisons in England and Wales.
The Directorate-General for Migration and Home Affairs (DG HOME) commissioned RAND Europe in partnership with Ernst & Young to undertake research to better understand the role of third-country workers in the long-term care sector in the EU.
Researchers are evaluating the UK Food Standards Agency's pilot Pathogen Surveillance in Agriculture, Food and the Environment (PATH-SAFE) Programme to assess whether it is improving detection of pathogens in the agri-food system and to enhance its success with recommendations for management.
RAND Europe mapped the existing tools and methods that aim to measure and/or improve the environmental sustainability of health research and assessed how these can be used and incorporated.
Changes to working practices and environments due to the COVID-19 pandemic may have affected exposure to known work-related musculoskeletal disorder (WRMSD) risk factors. Researchers studied this changing world of work, its effect on WRMSDs and post-pandemic considerations for WRMSDs.
Small and medium enterprises (SMEs) often find it hard to invest in the health and wellbeing of their employees, or do not invest at all. Researchers evaluated a randomised controlled trial of a financial incentive programme to improve employee health and wellbeing in SMEs in the West Midlands.
RAND Europe analyzed the legislation regarding psychosocial risks in the workplace and best practices in EU member states, with a view to making recommendations for how the EU can best support member states.
Researchers examined the possible effects of an experiment to cultivate and deliver quality-controlled cannabis through a closed supply chain for coffeeshops in the Netherlands.
Meeting the demand for musculoskeletal health care is a challenge for both health services and healthcare providers. RAND Europe assessed the cost-effectiveness of care and the direct access model of care.
RAND Europe researchers estimated that 2.4 million working adults could be infected with influenza, resulting in 4.8 million working days lost annually.
Innovation Fund Health-led Trials test new ways to address sickness absence and the disability employment gap due to two main conditions: mental health and musculoskeletal disorders. RAND Europe, together with partners, evaluated the effectiveness of these innovative interventions.
RAND Europe’s work is helping understand how to develop diagnostic Target Product Profiles for cancer and the types of features they need to cover to be useful for innovators, payers and health care professionals and patients.
An independent literature review analysed evidence to consider the positive and negative impacts on medicines pricing and innovation, and how these should be considered as part of the ongoing transparency and pricing debate.
RAND Europe researchers, along with University of Birmingham partners in the NIHR funded BRACE Rapid Evaluation Centre, evaluated home-based sensors with AI capabilities intended to help with adult social care.
